polyphenon造句

• As of October 2016, 20 clinical trials have been published for Polyphenon E ( 16 oral and 4 topical ).
• Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
• Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
• Phase Ib randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in patients with Barrett's Esophagus.
• Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signaling in women with hormone receptor-negative breast cancer.
• In 2006 the U . S . Food and Drug Administration has approved as a drug an ointment containing 15 % Polyphenon E for the treatment of genital and perianal warts.
• Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.
• Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E . Cancer Epidemiol Biomarkers Prev . 2001; 10 ( 1 ) : 53-8.
• Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, Bae SM, Lee IP . Protective effects of green tea extracts ( polyphenon E and EGCG ) on human cervical lesions.
• Dryden GW, Lam A, Beatty K, Qazzaz HH, McClain CJ . A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.
• 19 . Gross G, Meyer KG, Pres H, Thielert C, Tawfik H, Mescheder A . A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II / III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts.